West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,600 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
What is West Pharmaceutical Services Inc (WST)'s P/E Ratio?
The P/E ratio of West Pharmaceutical Services Inc is 46.7249
Who is the CEO of West Pharmaceutical Services Inc?
Mr. Eric Green is the Non-Independent Chairman of the Board of West Pharmaceutical Services Inc, joining the firm since 2015.
What is the price performance of WST stock?
The current price of WST is $316.53, it has increased 0.06% in the last trading day.
What are the primary business themes or industries for West Pharmaceutical Services Inc?
West Pharmaceutical Services Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is West Pharmaceutical Services Inc market cap?
West Pharmaceutical Services Inc's current market cap is $22.8B
Is West Pharmaceutical Services Inc a buy, sell, or hold?
According to wall street analysts, 17 analysts have made analyst ratings for West Pharmaceutical Services Inc, including 6 strong buy, 8 buy, 5 hold, 0 sell, and 6 strong sell